GET DAILY SIGNALSTriMas (TRS) Reports Q3 Sales Up +7.7% Amid Portfolio Focus
Key Takeaways
- TriMas reported third quarter 2026 net sales of $178.7 million, up 7.7% year over year, including 7.2% organic growth.
- Adjusted earnings per share (EPS) climbed to $0.50, up sharply from $0.17 in the prior-year period.
- Operating profit rose 47.9% to $13.6 million, with operating margin expanding 200 basis points to 7.6%.
- Results exceeded consensus, with adjusted EPS of $0.50 topping estimates and revenue of $178.7 million ahead of expectations.
- The company reaffirmed full-year 2026 adjusted EPS guidance of $1.60 to $1.70.
- TriMas announced an agreement to divest its Rapak flexible bag-in-box business as it sharpens its portfolio focus.
Why These Results Stand Out
TriMas Corporation (TRS) delivered its third-quarter 2026 numbers during a time of meaningful change. The company completed the sale of its TriMas Aerospace business back in March 2026, leaving a more focused operation centered on Packaging and Specialty Products. This report gives a clearer picture of the earnings potential of the streamlined business and how well cost-reduction and realignment efforts are progressing. It also highlights management’s ability to navigate issues at the Norris Cylinder operation while maintaining demand across packaging markets. With more than $1.1 billion in cash on the balance sheet, the quarter serves as an important checkpoint on near-term execution and capital discipline.
Breaking Down the Reported Figures
For the quarter ended September 30, 2026, net sales reached $178.7 million, a 7.7% increase from $166.0 million a year earlier, with organic growth of 7.2% driven by solid demand in both core segments. Operating profit increased 47.9% to $13.6 million and the operating margin widened 200 basis points to 7.6%, helped by cost actions and organizational changes. Adjusted EPS came in at $0.50 versus $0.17 in the same period last year. The company beat analyst expectations, with adjusted EPS surpassing the roughly $0.48 consensus and revenue exceeding the approximately $175 million estimate. Stronger profitability, higher interest income, and a lower share count from buybacks supported the improvement. Over the first nine months, net sales rose 6.4% to $521.6 million, operating profit climbed 35.8% to $41.2 million, and EPS more than doubled to $1.25. Management kept full-year 2026 adjusted EPS guidance at $1.60 to $1.70. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Specialty Products continued to feel the effects of throughput challenges at Norris Cylinder, while the rest of the portfolio performed well.
Market Reaction and Investor Views
Shares of TRS closed near $39.36 after the release. The stock has been down modestly over the past three months yet remains up about 10% over the trailing twelve months. Although the headline numbers topped estimates, reaction stayed measured because of ongoing operational issues at Norris Cylinder, where equipment and throughput problems continued to pressure margins. Investor sentiment balances confidence in the focused portfolio with caution around execution. The planned sale of the Rapak flexible bag-in-box business to Ringmetall reflects further portfolio simplification aimed at higher-value areas. The substantial cash position and active repurchase program add support while investors wait for clearer signs of margin recovery in Specialty Products.
Key Factors to Monitor Ahead
TriMas enters the fourth quarter with typical seasonal patterns, where the period usually brings the lowest revenue but the strongest free-cash-flow generation as working capital converts to cash. The biggest near-term item remains the turnaround at Norris Cylinder. Management noted that key equipment is running again and expects margin improvement in the fourth quarter, though a full return to earlier margin levels will require more time. Tracking machine uptime and throughput in Specialty Products will be important. Cost initiatives targeting $10.5 million in 2026 savings and $16 million annualized continue to matter. Resin costs and any ripple effects from the Middle East conflict also warrant attention given their impact on packaging inputs. Capital allocation remains central, with roughly $761 million in net cash and about $67 million left under the repurchase authorization, giving flexibility for acquisitions in packaging and life sciences or further returns to shareholders.
One Tool That Helps With Stock Analysis
In my own research, I often turn to Tickeron’s AI Screener to filter ideas and compare setups across industries. The tool lets users apply technical patterns, fundamentals, trends, and AI signals to scan thousands of stocks efficiently, which can surface relevant comparisons when evaluating companies like TRS after earnings.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
TRS in upward trend: 10-day moving average crossed above 50-day moving average on October 22, 2026
The 10-day moving average for TRS crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for TRS just turned positive on October 15, 2026. Looking at past instances where TRS's MACD turned positive, the stock continued to rise in 29 of 49 cases over the following month. The odds of a continued upward trend are 59%.
Following a +0.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where TRS advanced for three days, in 214 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 60 cases where TRS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 62%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TRS as a result. In 48 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.
TRS moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
TRS broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TRS entered a downward trend on September 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 15 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.962) is normal, around the industry mean (1.353). P/E Ratio (1.581) is within average values for comparable stocks, (16.257). Projected Growth (PEG Ratio) (0.540) is also within normal values, averaging (1.023). TRS has a moderately low Dividend Yield (0.004) as compared to the industry average of (0.033). P/S Ratio (2.285) is also within normal values, averaging (1.259).
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. TRS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 73 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of engineered and applied products
Industry ContainersPackaging
Advertisement